SYVN1 and breast cancer: In consequence, the stem cell traits acquired during EMT were partially reversed once accompanied by HRD1 overexpression (Fig. 4k), suggesting that HRD1-induced decline of Vimentin stability could prevent the generation of metastatic breast cancer stem cells (BCSCs).